×÷ΪÖйúµÚÈý·½¼ì²âÓëÈÏÖ¤·þÎñµÄ¿ªÍØÕߺÍÁìÏÈÕߣ¬NG28ÄϹ¬28NGÏàÐÅÆ·ÅÆÁ¦Á¿¼ì²âΪȫÇò¿Í»§Ìṩһվʽ¼ìÑé¡¢²âÊÔ¡¢Ð£×¼¡¢ÈÏÖ¤¼°¼¼Êõ·þÎñ¡£
·þÎñÄÜÁ¦ÒÑÈ«ÃæÁýÕÖµ½·ÄÖ¯·þ×°¼°Ð¬°ü¡¢Ó¤Í¯Íæ¾ß¼°¼Ò¾ÓÉú»î¡¢µç×ÓµçÆ÷¡¢Ò½Ñ§½¡¿µ¡¢Ê³Æ·¼°Å©²úÎï……µÈÐÐÒµµÄ¹©Ó¦Á´ÉÏÏÂÓΡ£
È«Ãæ±£ÕÏÆ·ÖÊÓëÄþ¾²£¬Íƶ¯ºÏ¹æÓ봴У¬ÕÃÏÔÆ·ÅƾºÕùÁ¦£¬ÊµÏÖ¸ü¸ßÖÊÁ¿¡¢¸ü½¡¿µ¡¢¸üÄþ¾²¡¢¸üÂÌÉ«µÄ¿ÉÁ¬ÐøÉú³¤¡£
Ê×Ò³ > ÎÒÃǵķþÎñ > Ò½Ò©¼°Ò½Ñ§·þÎñ > Ò½ÁÆÆ÷е¼ì²â > ·þÎñÏêÇé
NG28ÄϹ¬28NGÏàÐÅÆ·ÅÆÁ¦Á¿¼ì²âΪÄúÌṩ³¬Éù¶àÆÕÀÕÌ¥¶ù¼à»¤ÒÇ×¢²á¼ì²â½â¾ö·½°¸£¬¿ÉÁýÕֵļì²â·þÎñ·¶Î§ÓУºÒ½ÁÆÆ÷еµçÆøÄþ¾²¡¢EMC²âÊÔ¡¢ÉúÎïÏàÈÝÐÔ²âÊÔ¡¢°ü×°ÔËÊä¡¢ÇåÏ´Ïû¶¾Ãð¾úÑéÖ¤¡¢Èí¼þ²âÆÀ¼°ÍøÂçÄþ¾²²âÊԵȷþÎñ¡£
·çÏÕÆ·¼¶·ÖÀà
ÔÚÎÒ¹úµÄÒ½ÁÆÆ÷еע²á¹ÜÀíÖУ¬³¬Éù¶àÆÕÀÕÌ¥¶ù¼à»¤ÒÇ·çÏÕ¹ÜÀíÀà±ðÊôÓÚIIÀà;
Ì¥¶ù¼à»¤ÒÇ×¢²á¼ì²â
NG28ÄϹ¬28NGÏàÐÅÆ·ÅÆÁ¦Á¿¼ì²â¿ÉÒÔΪÄúÌṩ¡¾Ì¥¶ù¼à»¤ÒÇ¡¿×¢²á¼ì²â½â¾ö·½°¸£¬¿ÉÁýÕֵļì²â·þÎñ·¶Î§ÓУºÒ½ÁÆÆ÷еµçÆøÄþ¾²¡¢EMC²âÊÔ¡¢ÉúÎïÏàÈÝÐÔ²âÊÔ¡¢°ü×°ÔËÊä¡¢ÇåÏ´Ïû¶¾Ãð¾úÑéÖ¤¡¢Èí¼þ²âÆÀ¼°ÍøÂçÄþ¾²²âÊԵȷþÎñ¡£
Ì¥¶ù¼à»¤ÒDzâÊԳ߶È
¹úÄÚ×¢²á-¼ì²â·½°¸
ÏîĿ˵Ã÷ | ³ß¶È±àºÅ | ³ß¶ÈÃû³Æ |
°²¹æ | GB 9706.1-2020 | Ò½ÓõçÆøÉ豸 µÚ1²¿ÃÅ£º»ù±¾Äþ¾²ºÍ»ùÌìÐÔÄܵÄͨÓÃÒªÇó |
YY/T 9706.106-2021 | Ò½ÓõçÆøÉ豸 µÚ 1-6 ²¿ÃÅ£º»ù±¾Äþ¾²ºÍ»ùÌìÐÔÄܵÄͨÓÃÒªÇó - ²¢Áг߶ȣº¿ÉÓÃÐÔ | |
YY 9706.108-2021 | Ò½ÓõçÆøÉ豸ºÍÒ½ÓõçÆøϵͳÖб¨¾¯ÏµÍ³µÄ²âÊÔºÍÖ¸ÄÏ | |
GB 9706.237-2020 | Ò½ÓõçÆøÉ豸 µÚ2-37²¿ÃÅ£º³¬ÉùÕï¶ÏºÍ¼à»¤É豸µÄ»ù±¾Äþ¾²ºÍ»ùÌìÐÔÄÜרÓÃÒªÇó | |
YY/T 0449-2019 | ³¬Éù¶àÆÕÀÕÌ¥¶ù¼à»¤ÒÇ | |
GB/T 14710-2009 | Ò½ÓõçÆ÷»·¾³ÒªÇó¼°ÊÔÑéÒªÁì | |
EMC | YY 9706.102-2021 | Ò½ÓõçÆøÉ豸 µÚ1-2²¿ÃÅ£º»ù±¾Äþ¾²ºÍ»ùÌìÐÔÄܵÄͨÓÃÒªÇó ²¢Áг߶ȣºµç´Å¼æÈÝÒªÇóºÍÊÔÑé |
ÉúÎïÏàÈÝÐÔ | GB/T 16886.1-2022 | Ò½ÁÆÆ÷еÉúÎïѧÆÀ¼Û µÚ1²¿ÃÅ£º·çÏÕ¹ÜÀí¹ý³ÌÖеÄÆÀ¼ÛÓëÊÔÑé |
GB/T 16886.5-2017 | Ò½ÁÆÆ÷еÉúÎïѧÆÀ¼Û µÚ5²¿ÃÅ£ºÌåÍâϸ°û¶¾ÐÔÊÔÑé | |
GB/T 16886.10-2017 | Ò½ÁÆÆ÷еÉúÎïѧÆÀ¼Û µÚ10²¿ÃÅ£º´Ì¼¤ÓëƤ·ôÖÂÃôÊÔÑé | |
GB/T 16886.23-2023 £¨2024-12-01ʵʩ£© |
Ò½ÁÆÆ÷еÉúÎïѧÆÀ¼Û µÚ23²¿ÃÅ£º´Ì¼¤ÊÔÑé | |
°ü×°ÔËÊä | GB /T 4857 | °ü×°ÔËÊäÊÔÑé |
ÇåÏ´¡¢Ïû¶¾¡¢Ãð¾úÖ¤ÑéÖ¤ | WS 310.1 / WS 310.2 / WS 310.3/ WS/T 367 / W S 506 |
ÇåÏ´Ïû¶¾Ãð¾úÑéÖ¤ |
Èí¼þ²âÆÀ¼°ÍøÂçÄþ¾²²âÊÔ | GB/T 25000.51 | ¡¶ÏµÍ³ÓëÈí¼þ¹¤³ÌϵͳÓëÈí¼þÖÊÁ¿ÒªÇóºÍÆÀ¼Û£¨SQuaRE£© µÚ51²¿ÃÅ£º¾ÍÐ÷¿ÉÓÃÈí¼þ²úÎRUSP£©µÄÖÊÁ¿ÒªÇóºÍ²âÊÔϸÔò¡· |
GB/T 25000.10 | ¡¶ÏµÍ³ÓëÈí¼þ¹¤³ÌϵͳÓëÈí¼þÖÊÁ¿ÒªÇóºÍÆÀ¼Û£¨SQuaRE£©µÚ10²¿ÃÅ£ºÏµÍ³ÓëÈí¼þÖÊÁ¿Ä£ÐÍ¡· | |
YY/T 1843-2022 | Ò½ÓõçÆøϵͳ¼°Ò½ÁÆÆ÷еÈí¼þµÄÍøÂçÄþ¾²»ù±¾ÒªÇó |
¹ú¼Ê×¢²á-¼ì²â·½°¸
ÏîĿ˵Ã÷ |
³ß¶È±àºÅ |
³ß¶ÈÃû³Æ |
°²¹æ
|
IEC 60601-1:2005/COR3:2022 |
Ò½ÓõçÆøÉ豸 µÚ1²¿ÃÅ£º»ù±¾Äþ¾²ºÍ»ùÌìÐÔÄܵÄͨÓÃÒªÇó |
IEC 60601-1-6:2010+A1:2013+A2:2020 |
Ò½ÓõçÆøÉ豸 µÚ 1-6 ²¿ÃÅ£º»ù±¾Äþ¾²ºÍ»ùÌìÐÔÄܵÄͨÓÃÒªÇó - ²¢Áг߶ȣº¿ÉÓÃÐÔ |
|
IEC 60601-1-8:2006+A2:2020 |
Ò½ÓõçÆøÉ豸ºÍÒ½ÓõçÆøϵͳÖб¨¾¯ÏµÍ³µÄ²âÊÔºÍÖ¸ÄÏ |
|
IEC 60601-2-37:2007+AMD1:2015 |
Ò½ÓõçÆøÉ豸 µÚ2-37²¿ÃÅ£º³¬ÉùÕï¶ÏºÍ¼à»¤É豸µÄ»ù±¾Äþ¾²ºÍ»ùÌìÐÔÄÜרÓÃÒªÇó |
|
EMC |
IEC 60601-1-2:2014+A1:2020 |
Ò½ÓõçÆøÉ豸 µÚ1-2²¿ÃÅ£º»ù±¾Äþ¾²ºÍ»ùÌìÐÔÄܵÄͨÓÃÒªÇó ²¢Áг߶ȣºµç´Å¼æÈÝÒªÇóºÍÊÔÑé |
ÉúÎïÏàÈÝÐÔ
|
ISO 10993-1:2018 |
Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process |
ISO 10993-5:2009 |
Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity |
|
ISO 10993-10:2021 |
Biological evaluation of medical devices Part 10: Tests for skin sensitization |
|
ISO 10993-23:2021 |
Biological evaluation of medical devices Part 23: Tests for irritation |
|
°ü×°ÔËÊä |
ISTAϵÁÐ / ASTMD 4169 |
°ü×°ÔËÊäÊÔÑé |
ÇåÏ´¡¢Ïû¶¾¡¢Ãð¾úÖ¤ÑéÖ¤ |
AAMI TIR12£»AAMI TIR30 £» FDA Guidance |
ÇåÏ´Ïû¶¾¼°Ãð¾ú¼¼Êõ²Ù×÷¹æ·¶ |
±¸×¢£ºÉÏÊö³ß¶È°üÂÞÁ˲úÎï¼¼ÊõÒªÇóÖо³£Éæ¼°µ½µÄ³ß¶È£»ÆóÒµÐèҪƾ¾Ý²úÎïµÄÌصãÒýÓÃÆäËûÊÊÓõij߶ȡ£
ÍêÕûÄÜÕý³£ÊÂÇéµÄÑù»ú£¬ÆäËû¾ßÌåÏêÇéÇë×ÉѯNG28ÔÚÏß¿Í·þ¡£
1¡¢NG28¾ßÓÐרҵ×ÊÖÊ¡¢¾Ñ鸻ºñµÄ¼¼Êõר¼ÒÍŶӣ¬ÎªÄúÌṩרҵ×ÉѯºÍ·þÎñ¡£
2¡¢NG28ÓµÓÐÏȽøµÄʵÑéÊÒÉ豸£¬È·±£²âÊÔÊý¾ÝµÄ׼ȷºÍ¿É¿¿¡£
3¡¢NG28×÷ΪȫÇò¿Í»§ÐÅÀµµÄµÚÈý·½²âÊÔÈÏÖ¤»ú¹¹£¬ÎÒÃÇÊÇÄúÆ·Öʵı³Êé¡£
4¡¢ÎÒÃÇƾ½è±é²¼È«ÇòµÄʵÑéÊÒÍøÂ磬ΪÄúÌṩȫÃæÍêÉƵÄһվʽ²âÊÔÈÏÖ¤½â¾ö·½°¸¡£
NG28µÄÒ½ÁÆÆ÷е¼ì²âµÄ²âÊÔÖÜÆÚÊǶà¾Ã£¿
ʵ¼ÊÖÜÆÚƾ¾ÝίÍеIJúÎï³ß¶ÈÀ´È·¶¨£¬ÇëÓëNG28¿Í·þÁªÏµÈ·ÈÏ¡£
NG28Ò½ÁÆÆ÷е¼ì²âµÄ²âÊÔÒªÁìÊÇʲô£¿
Õë¶Ô²úÎïµÄ³ö¿ÚÒªÒÔ¼°¿Í»§Î¯ÍеÄÒªÇ󣬽øÐг߶ȼì²â¡£
NG28¶ÔÓÚÑùÆ·µÄÁôÑùÖÜÆÚÊǶà¾Ã£¿
ÍËÑù¡£